Pilot Study of Ultrasound in Rheumatoid Arthritis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-02-28

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Little is currently known as to the predictive value of ultrasound in guiding the decision to taper drug treatment in patients with stable rheumatoid arthritis, nor the influence that patients' views and opinions regarding their medications may have upon this. In this study, patients with stable rheumatoid arthritis will undergo a simple examination of their joints to look for any swelling or tenderness followed by an ultrasound scan to look for joint inflammation. Half of the patients will also complete an interview to assess their views and opinions of arthritis drug treatment. The study will be completed in a single patient visit - no invasive tests will be performed, and no changes to treatment will be made.

This study is being conducted as part of a Masters degree from Newcastle University. The results of this study will be used to inform the feasibility of inclusion of ultrasound assessment within the design of a future PhD study to investigate potential markers of remission in patients with rheumatoid arthritis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ultrasound Utility in Routine Clinical Practise

NCT03124225

Arthritis, Rheumatoid Ultrasonography

COMPLETED

Musculoskeletal Ultrasound with Elastography in the Evaluation of Muscle State in Rheumatoid Arthritis Patients

NCT06620484

Rheumatoid Arthritis Musculoskeletal Ultrasound

NOT_YET_RECRUITING

Ultrasonography as a Biomarker in Early Rheumatoid Arthritis

NCT00781989

Rheumatoid Arthritis

COMPLETED

Ultrasound Efficacy in Moderate Rheumatoid Arthritis

NCT04662359

Rheumatoid Arthritis

COMPLETED NA

Ultrasonographic Evaluation of Asymptomatic Shoulder Joint Pathologies in Rheumatoid Arthritis Patients

NCT06572696

Rheumatoid Arthritis Shoulder Injuries and Disorders

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational study group

Musculoskeletal ultrasound (all patients) and semi-structured patient interview (anticipated maximum 15 patients)

Musculoskeletal Ultrasound

Intervention Type OTHER

7-joint musculoskeletal ultrasound scan

Semi-structured patient interview

Intervention Type OTHER

Semi-structured patient interview

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Musculoskeletal Ultrasound

7-joint musculoskeletal ultrasound scan

Intervention Type OTHER

Semi-structured patient interview

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of rheumatoid arthritis with symptom onset at least 12 months previously
* Current disease-modifying anti-rheumatic drug (DMARD) therapy or biologic therapy
* Currently stable arthritis defined as no change in DMARD treatment over previous 6 months, and no use of steroids (enteral, parenteral or intra-articular) over previous 6 months